Motley Fool Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Motley Fool Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-877,667	Closed	-$2.49M	–	166
2020 Q3	$2.49M	Buy	877,667 +258,077	+42%	+$714K	0.22%	83
2020 Q2	$1.7M	Buy	619,590 +53,658	+9%	+$150K	0.17%	85
2020 Q1	$1.34M	Sell	565,932 -4,878	-0.9%	-$16.6K	0.17%	86
2019 Q4	$2.68M	Sell	570,810 -19,512	-3%	-$79.8K	0.29%	65
2019 Q3	$1.98M	Buy	590,322 +393,522	+200%	+$1.3M	0.23%	73
2019 Q2	$647K	Buy	+196,800	New	+$569K	0.07%	128

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Motley Fool Asset Management's ATRS Position: Q4 2020 in Review

Motley Fool Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q4 2020, closing a stake of 877,667 shares — an estimated $2.49M sold.

Motley Fool Asset Management first reported a position in ATRS in Q2 2019 and held it in 6 quarters. The position peaked at $2.68M in Q4 2019. 174 funds tracked by Wall St. Rank hold ATRS as of Q4 2020.

Motley Fool Asset Management reported no remaining Antares Pharma, Inc. position as of Q4 2020 after selling out during the quarter.
Motley Fool Asset Management sold 877,667 Antares Pharma, Inc. shares in Q4 2020, an estimated $2.49M.
Motley Fool Asset Management first reported a position in Antares Pharma, Inc. in Q2 2019 and held it in 6 quarters.
Motley Fool Asset Management's Antares Pharma, Inc. position peaked at $2.68M in Q4 2019.
174 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2020.

Based on Motley Fool Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.